Related Experiment Video
Updated: Jan 15, 2026

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Comparative analysis of cardiometabolic multimorbidity predictors in China and the USA: A machine learning approach
Jingjing Zhu1, Zumin Shi2, Zongyuan Ge3
1School of Public Health, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Insights
Developing a bidirectional machine learning model for cardiometabolic multimorbidity (CMM) screening identified key risk factors. Tailored screening strategies for China and the USA improve early detection of cardiovascular disease (CVD) and metabolic diseases (MD).
Area of Science:
- Public Health
- Computational Biology
- Epidemiology
Background:
- Cardiometabolic multimorbidity (CMM), the co-occurrence of cardiovascular disease (CVD) and metabolic diseases (MD), poses a significant global health challenge.
- Current screening tools for CMM are insufficient and lack applicability across different nations, particularly between the USA and China.
- There is a critical need for advanced, cross-nationally applicable screening methods to identify individuals at risk for CMM.
Purpose of the Study:
- To develop and validate a bidirectional machine learning (ML) model for predicting cardiometabolic multimorbidity (CMM) risk.
- To identify distinct and shared risk factors for CMM in China and the USA.
- To enable precision screening and inform region-specific public health interventions for CMM.
Main Methods:
- Utilized data from the Chinese Health and Retirement Longitudinal Survey (CHARLS) and the US Health and Retirement Study (HRS).
- Developed and compared bidirectional ML models, including logistic regression (LR), Gaussian Naive Bayes (GNB), and extreme gradient boosting (XGBoost).
- Evaluated model performance using Area Under the Curve (AUC) and performed cross-national validation with SHAP analysis for predictor identification.
Main Results:
- Logistic regression models demonstrated strong performance in predicting cardiovascular disease (CVD) (AUC = 0.70 in both countries).
- Predictive accuracy for metabolic diseases (MD) varied, with LR (AUC = 0.71) excelling in China and GNB (AUC = 0.65) in the USA.
- Core predictors included disease counts and moderate physical activity, with unique regional predictors identified, such as grip strength in China and pulse/emotional problems in the USA.
Conclusions:
- A validated, bidirectional ML model offers a promising tool for precision CMM screening across different countries.
- Region-specific screening strategies are recommended, emphasizing grip strength and balance for China and pulse monitoring and psychological interventions for the USA.
- This approach facilitates targeted public health interventions to mitigate the burden of cardiometabolic multimorbidity.
Background:
Cardiometabolic multimorbidity (CMM) - coexisting cardiovascular disease (CVD) and metabolic diseases (MD) - represents a major public health challenge in the USA and China, but early screening tools remain inadequate and lack cross-national applicability. We aim to build bidirectional model to determine risk factors in different countries.
Methods:
We utilised data from CHARLS (China, n = 3,401 CVD/n = 797 MD) and HRS (USA, n = 3,533 CVD/n = 1,507 MD) to develop bidirectional machine learning (ML) prediction models including logistic regression (LR), gaussian naive Bayes (GNB), and extreme gradient boosting (XGBoost), evaluating with AUC and validating across nations. SHAP analysis identified consistent and varied risk predictors.
Results:
LR (AUC = 0.70 in both countries) were best in CVD prediction, LR (AUC = 0.71 in China) and GNB (AUC = 0.65 in USA) were best in MD prediction. Model performance decreased during external validation. Core predictors included disease counts and moderate physical activity. Priority predictors differed: pulse, mild physical activity, emotional problems and falling in USA; full-tandem stance and left hand's grip strength in China.
Conclusions:
Our bidirectional, cross-nationally validated ML model enables precision CMM screening. Region-specific strategies are advised: China should prioritize grip strength and balance screening, while the USA focuses on pulse monitoring and psychological interventions.
More Related Videos
07:35Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
03:05Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
Published on: November 21, 2025
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Coronary Artery Disease I: Introduction